ANNOVIS BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.01 USD | +32.43% |
|
+79.03% | -3.69% |
Chart calendar Annovis Bio, Inc.
89315412bef380d60e.8eGwkV1wVTNXOQ9KKxu6HddqsW9uUGN9zaQ6I5ySdMQ.vIjKxAQZI3gEW3UyTCzxW7Iw5A0YBltPv-ADevfHPbyFlNz0DwdmShVPPw~21195eb51854276c2094b18a827d4f26
Upcoming events on Annovis Bio, Inc.
Past events on Annovis Bio, Inc.
| 02/04/2024 12:30 | Q4 2023 Earnings Release |
| 07/03/2024 17:30 | Alzheimer and Parkinson Diseases International Conference - Panel |
| 10/12/2023 | Yale CEO Summit |
| 08/11/2023 22:00 | Q3 2023 Earnings Release |
| 23/10/2023 | Clinical Trials on Alzheimer Disease Conference |
| 19/10/2023 13:30 | ThinkEquity Conference |
| 11/10/2023 | Dawson James Small Cap Growth Conference |
| 15/08/2023 12:20 | Q2 2023 Earnings Release |
| 15/07/2023 | Alzheimer Association International Conference |
| 20/06/2023 18:00 | Maxim Group Virtual Healthcare Conference |
| 15/06/2023 15:00 | Annual General Meeting |
| 11/05/2023 12:00 | Q1 2023 Earnings Release |
| 20/04/2023 21:00 | R&D Day |
| 03/04/2023 12:30 | Q4 2022 Earnings Release |
| 30/03/2023 | AD/PD International Alzheimer and Parkinson Disease Conference - Abstract No 3114 |
| 29/03/2023 | Alzheimer & Parkinson Disease International Conference - Abstract No 3080 |
| 26/10/2022 14:00 | ThinkEquity Conference |
| 29/09/2022 17:30 | Ladenburg Thalmann Healthcare Conference |
| 08/08/2022 12:30 | Interim 2022 Earnings Release |
| 04/08/2022 16:00 | Alzheimer Association International Conference - Panel |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -45,0 -45,6 1.24% | -37,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -14,5 -10,6 -36.72% | -25,5 -31,0 17.59% | -45,0 -47,5 5.09% | -31,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -14,5 -10,6 -36.83% | -25,3 -30,8 17.89% | -56,2 -47,6 -18.16% | -34,0 |
|
Net income Million USD | Released Forecast Spread | -5,46 | -14,5 -10,6 -36.83% | -25,3 -30,8 17.89% | -56,2 -47,6 -18.16% | -34,0 |
|
EPS USD | Released Forecast Spread | -0,87 | -1,90 -1,39 -36.69% | -3,10 -3,77 17.84% | -6,23 -5,14 -21.25% | -2,78 |
| Announcement Date | 03/03/21 | 02/03/22 | 31/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -10,4 -11,0 5.07% | -6,40 | -6,70 | -11,9 | -12,4 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -5,92 -2,02 -193.66% | -5,91 -5,48 -7.92% | -8,75 -5,88 -49.01% | -7,67 -8,36 8.24% | -3,17 -8,63 63.29% | -9,97 -5,56 -79.31% | -9,76 -10,6 7.97% | -14,9 -10,5 -41.47% | -10,4 -12,9 18.77% | -7,50 | -6,65 | -8,75 | -8,50 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,91 -2,02 -193.38% | -5,89 -4,72 -25.01% | -8,72 -5,34 -63.32% | -7,62 -8,36 8.84% | -3,09 -8,62 64.09% | -9,74 -5,51 -76.78% | -9,54 -10,5 9.13% | -14,7 -10,4 -41.54% | -22,2 -13,6 -63.66% | -8,49 | -7,50 | -9,02 | -8,92 | |
|
Net income Million USD | Released Forecast Spread | -5,91 -2,02 -193.38% | -5,89 -5,48 -7.61% | -8,70 -5,87 -48.15% | -7,62 -8,36 8.84% | -3,09 -8,62 64.09% | -9,74 -5,51 -76.78% | -9,54 -10,5 9.13% | -14,7 -10,4 -41.54% | -22,2 -13,6 -63.66% | -8,49 | -7,50 | -9,02 | -8,92 | |
|
EPS USD | Released Forecast Spread | -0,75 -0,25 -200% | -0,72 -0,67 -7.46% | -1,07 -0,71 -50.7% | -0,93 -1,01 8.22% | -0,38 -1,05 63.92% | -1,19 -0,59 -101.69% | -1,07 -1,14 6.14% | -1,63 -1,09 -49.54% | -2,33 -1,37 -69.58% | -0,78 | -0,58 | -0,63 | -0,62 | -0,48 |
| Announcement Date | 02/03/22 | 04/05/22 | 08/08/22 | 08/11/22 | 31/03/23 | 10/05/23 | 14/08/23 | 08/11/23 | 29/03/24 | - | - | - | - | - |
More events
Past sector events for Annovis Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANVS Stock
- Calendar Annovis Bio, Inc.
